Luxbright AB (LXB) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.321x

Based on the latest financial reports, Luxbright AB (LXB) has a cash flow conversion efficiency ratio of -0.321x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-8.63 Million ≈ $-928.73K USD) by net assets (Skr26.89 Million ≈ $2.89 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Luxbright AB - Cash Flow Conversion Efficiency Trend (2017–2025)

This chart illustrates how Luxbright AB's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Luxbright AB debt and liabilities for a breakdown of total debt and financial obligations.

Luxbright AB Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Luxbright AB ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
CPT GLOBAL LTD F:714	N/A
Fluicell AB ST:FLUI	-0.114x
International Prospect Ventures Ltd V:IZZ	-0.357x
Martello Technologies Group Inc V:MTLO	0.035x
CCSC Technology International Holdings Limited Ordinary Shares NASDAQ:CCTG	-0.004x
Propanc Biopharma, Inc. Common Stock NASDAQ:PPCB	-0.096x
AFC Energy plc LSE:AFC	-0.349x
Nextferm Technologies Ltd TA:NXFR	N/A

Annual Cash Flow Conversion Efficiency for Luxbright AB (2017–2025)

The table below shows the annual cash flow conversion efficiency of Luxbright AB from 2017 to 2025. For the full company profile with market capitalisation and key ratios, see market value of Luxbright AB.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	Skr26.89 Million ≈ $2.89 Million	Skr-19.87 Million ≈ $-2.14 Million	-0.739x	-53.00%
2024-12-31	Skr34.20 Million ≈ $3.68 Million	Skr-16.52 Million ≈ $-1.78 Million	-0.483x	+20.21%
2023-12-31	Skr33.69 Million ≈ $3.63 Million	Skr-20.39 Million ≈ $-2.19 Million	-0.605x	+18.30%
2022-12-31	Skr27.86 Million ≈ $3.00 Million	Skr-20.64 Million ≈ $-2.22 Million	-0.741x	+10.85%
2021-12-31	Skr20.63 Million ≈ $2.22 Million	Skr-17.14 Million ≈ $-1.84 Million	-0.831x	-134.92%
2020-12-31	Skr38.64 Million ≈ $4.16 Million	Skr-13.67 Million ≈ $-1.47 Million	-0.354x	+72.43%
2019-12-31	Skr10.50 Million ≈ $1.13 Million	Skr-13.47 Million ≈ $-1.45 Million	-1.283x	+20.60%
2018-12-31	Skr6.90 Million ≈ $742.52K	Skr-11.15 Million ≈ $-1.20 Million	-1.616x	-170.28%
2017-12-31	Skr-5.94 Million ≈ $-639.77K	Skr-13.67 Million ≈ $-1.47 Million	2.299x	--

About Luxbright AB

ST:LXB Sweden Medical Devices

Market Cap

$2.10 Million

Skr19.52 Million SEK

Market Cap Rank

#29639 Global

#689 in Sweden

Share Price

Skr0.15

Change (1 day)

+7.14%

52-Week Range

Skr0.12 - Skr0.80

All Time High

Skr3.85